US pharma major AbbVie (NYSE: ABBV) has filed a lawsuit seeking to narrow the definition of a “340B patient,” opening a new ...

This proposal is a way to recover ancestral knowledge to shape our cities and rural environments. It advocates for ...

Immunocompetent adults younger than 50 years of age experience a substantial HZ burden, with incidence rates comparable to older age groups.

In the United States, the biotech industry is going through a delicate moment: company valuations have dropped, investors are ...

In 1981, CT helped evangelicals navigate debates over Ronald Reagan, genetic engineering, television, and male headship.

In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...

No. 7 / 2026  Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant ...

In the latest meeting minutes released by the US Food and Drug Administration (FDA), the agency noted that significant ...

According to entrepreneur Artem Sokolov, Founder and CEO of Humanoid, the real challenge facing modern economies is how ...

Katie Chaffin peered into a device that resembled a virtual reality headset, squeezed a pair of hand controllers and across ...

The gap between innovation and commercialization is known as the “valley of death” for a reason. The longer companies spend ...

Pancreatic Cancer Phase 2a study in pancreatic cancer met its primary endpoint of safety in heavily pretreated patients. The study continues to follow patients for overall survival, with data maturing ...